Immunocombination therapy for high-risk neuroblastoma.

Immunotherapy

Volumn 4, Issue 2, 2012, Pages 163-174

  Kroesen, Michiel ^a   Lindau, Dennis ^b   Hoogerbrugge, Peter ^b   Adema, Gosse J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; ADOPTIVE IMMUNOTHERAPY; ANIMAL; AUTONOMIC NEUROPATHY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METHODOLOGY; MOLECULARLY TARGETED THERAPY; MULTIMODALITY CANCER THERAPY; NEUROBLASTOMA; PATHOLOGY; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTONOMIC NERVOUS SYSTEM DISEASES; COMBINED MODALITY THERAPY; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY, ADOPTIVE; MOLECULAR TARGETED THERAPY; NEUROBLASTOMA;

EID: 84861923685     PISSN: None     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.11.169     Document Type: Review

References (0)